Cargando…
Evolving role of Sorafenib in the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignant diseases worldwide and comes third in cancer-related mortality. Although there is a broad spectrum of treatment options to choose from, only a few patients are eligible candidates to receive a curative therapy according to their stag...
Autores principales: | Ziogas, Ioannis A, Tsoulfas, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465010/ https://www.ncbi.nlm.nih.gov/pubmed/28638790 http://dx.doi.org/10.5306/wjco.v8.i3.203 |
Ejemplares similares
-
Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017) -
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances
por: Rallis, Kathrine S, et al.
Publicado: (2022) -
Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities
por: Christou, Chrysanthos D, et al.
Publicado: (2022) -
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
por: Pan, Jen-Jung, et al.
Publicado: (2010) -
Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review †
por: Kakos, Christos D., et al.
Publicado: (2022)